Drug Made From Cannabis Plant Gets Backing From FDA Staff

Tuesday, May 22, 2018

The treatment, which GW Pharma hopes to market under the nameĀ Epidiolex, is produced in the U.K. from a plant that has been bred to have a high cannabidiol, or CBD, content, Chief Executive Officer Justin Gover said in an interview earlier this month. The chemical is purified and made into a strawberry-flavored oral solution, he said.